Showing 11-20 of 36 grants
| Title | Institution | Researcher | Program | Duration | Total Award Amount |
|---|---|---|---|---|---|
| Digital Resources for India – Pilot Project | Digibete | John Hughes | Improving Lives | 01-March-2025 to 29-February-2028 | $213.785,00 |
| Profiling The Kinome In Type 1 Diabetes; Identifying Novel Targets For Biomarker Development and Disease-modifying Therapies | University of Bristol | Anna Long | Cures | 01-April-2025 to 30-September-2026 | $197.076,23 |
| Are we missing something – do the small things matter? | University of Exeter | Sarah Richardson | Cures | 01-May-2025 to 30-April-2028 | $994.000,00 |
| Establishing the effectiveness, safety and acceptability of treatments to preserve beta cell function in people with type 1 diabetes (T1D) | University of Birmingham | Parth Narendran | Cures | 01-September-2024 to 31-August-2027 | $279.997,78 |
| Targeting the chemokine network in insulitis | University of Oxford | Shoumo Bhattacharya | Cures | 01-April-2025 to 30-September-2026 | $171.799,00 |
| The L selectin pathway in type 1 diabetes | University of Bristol | Kathleen Gillespie | Cures | 01-September-2024 to 31-August-2027 | $827.321,85 |
| Targeting the islet resident immune population to prevent T1D | King's College London | Gavin Bewick | Cures | 01-October-2024 to 30-September-2027 | $899.758,00 |
| Development of a point of care immunosensor for c-peptide assessment | Lancaster University | Samet Sahin | Cures | 01-December-2024 to 30-November-2027 | $558.291,85 |
| Home-based measures of beta-cell function and CGM metrics to predict progression of pre-symptomatic individuals | University of Cambridge | M. Loredana Marcovecchio | Cures | 01-October-2024 to 30-September-2027 | $855.740,85 |
| Progressing 4 antibody multiplex Lateral flow assay for Diabetes (Diabetes 4ward) | University of Birmingham | Alex Richter | Cures | 01-August-2024 to 31-July-2026 | $705.592,01 |